6-Hydroxydopamine hydrobromide
ALDRICH/162957 - 95%
Synonym: 2,4,5-
CAS Number: 636-00-0
Empirical Formula (Hill Notation): C8H11NO3 · HBr
Molecular Weight: 250.09
EC Number: 211-247-0
MDL Number: MFCD00012894
Linear Formula: (HO)3C6H2CH2CH2NH2 · HBr
Product Type: Chemical
assay | 95% |
form | powder |
InChI | 1S/C8H11NO3.BrH/c9-2-1-5- |
InChI key | MLACDGUOKDOLGC-UHFFFAOYSA |
mp | 216-220 °C (lit.) |
Quality Level | 100 |
SMILES string | Br.NCCc1cc(O)c(O)cc1O |
storage temp. | −20°C |
Application: | 6-Hydroxydopamine hydrobromide has been used: • to induce Parkinson′s disease (PD) in mouse models to study the effects of tubastatin A (TBA) on nucleotide-binding oligomerization domain and leucine-rich repeat pyrin 3 domain (NLRP3) activation and cell injury in SH-SY5Y cells • to induce pharmacological ablation of the sympathetic nerves to study the effect of hepatic sympathetic nerve activity (SNA) on hepatic steatosis during diet-induced obesity in mice • to induce oxidative stress in mesencephalic cells to study its effect on p75NTR signaling in neuronal cells of the ventral mesencephalon |
Biochem/physiol Actions: | 6-Hydroxydopamine hydrobromide (6-OHDA) is a neurotoxin that elicits oxidative damage and destroys catecholaminergic or sympathetic terminals. It is commonly used to induce Parkinson′s disease in the experimental model. 6-OHDA exerts cytotoxicity by generating reactive oxygen species, initiating cellular stress and cell death. |
General description: | Solutions should be freshly prepared and protected from exposure to light. |
Packaging: | 1, 5 g in glass bottle |
Packaging: | 50, 250 mg in glass insert |
Symbol | GHS07 |
Signal word | Warning |
Hazard statements | H315 - H319 - H335 |
Precautionary statements | P302 + P352 - P305 + P351 + P338 |
Hazard Codes | Xi |
Risk Statements | 36/37/38 |
Safety Statements | 26-36 |
RIDADR | NONH for all modes of transport |
WGK Germany | WGK 3 |
Purity | 95% |
mp | 216-220 °C (lit.) |
Storage Temp. | −20°C |
UNSPSC | 12352116 |